Bioasis Technologies (BIOAF) Stock Price, News & Analysis

Company Overview

Bioasis Technologies Inc. is a biotechnology company focused on developing therapies for diseases affecting the central nervous system. The company’s research centers on its proprietary xB3 platform, which is designed to help transport therapeutic molecules across the blood-brain barrier, a major challenge in the development of treatments for neurological disorders.

Bioasis has pursued potential applications of the xB3 platform in areas including neurodegenerative disease and other central nervous system conditions. Its development work has included biologic-based therapeutic candidates intended to improve the delivery of medicines to the brain, although the company’s programs remain subject to research, clinical development, regulatory review and commercial uncertainty.

The company has historically operated as a Canadian biotechnology enterprise and has sought collaborations and licensing opportunities to advance its platform and product candidates. Publicly available information about its current operations, leadership and geographic commercial presence is limited, so no additional details are included here.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 8,471 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 10/27/2021
• Today: 9/23/2026
• Fiscal Year End: 2/28/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:BIOAF
• CIK: N/A
• Web: www.bioasis.us
• Phone: (203) 533-7082
• Fax: N/A
• Employees: N/A
• Year Founded: 2007

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A